Get the Stockscreener App
0.00
100.00%
-0.2001
After Hours:
.18
0.18
+
Unity Biotechnology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
See More
Previous Close:
$0.2001
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$13.94M
Revenue:
-
Net Income/Loss:
$-52.53M
P/E Ratio:
0.00
EPS:
-3.66
Net Cash Flow:
$-39.93M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.10
Unity Biotechnology Inc Stock (UBX) Company Profile
Name
Unity Biotechnology Inc
Sector
Industry
Phone
(650) 416-1192
Address
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Compare UBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UBX
Unity Biotechnology Inc
|
0.00 | 13.94M | 0 | -52.53M | -39.93M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-16-25 | Downgrade | Mizuho | Outperform → Neutral |
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-16-23 | Upgrade | Wedbush | Neutral → Outperform |
| Jan-04-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Nov-10-21 | Upgrade | Mizuho | Neutral → Buy |
| Jun-28-21 | Upgrade | Citigroup | Sell → Buy |
| Jun-07-21 | Initiated | H.C. Wainwright | Buy |
| Feb-16-21 | Downgrade | Citigroup | Neutral → Sell |
| Aug-18-20 | Downgrade | Citigroup | Buy → Neutral |
| Aug-18-20 | Downgrade | Mizuho | Buy → Neutral |
| Aug-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-17-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-28-20 | Initiated | ROTH Capital | Buy |
| Dec-12-19 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-19 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-07-18 | Initiated | Mizuho | Buy |
| May-29-18 | Initiated | Citigroup | Buy |
| May-29-18 | Initiated | Goldman | Neutral |
| May-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Unity Biotechnology Inc Stock (UBX) Latest News
What indicators show strength in Unity Biotechnology Inc.Quarterly Trade Report & Breakout Confirmation Alerts - newser.com
When is the best time to exit Unity Biotechnology Inc.Earnings Growth Report & Smart Investment Allocation Tips - newser.com
Published on: 2025-09-14 15:41:36 - newser.com
Can Unity Biotechnology Inc. rally from current levels2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Real time pattern detection on Unity Biotechnology Inc. stockNew Guidance & Free Real-Time Volume Trigger Notifications - newser.com
Candlestick signals on Unity Biotechnology Inc. stock todayJuly 2025 Recap & Capital Efficiency Focused Ideas - newser.com
Is Unity Biotechnology Inc. forming a reversal pattern2025 Support & Resistance & Momentum Based Trading Signals - newser.com
Will Unity Biotechnology Inc. continue its uptrendWeekly Gains Report & Reliable Intraday Trade Plans - Newser
Applying chart zones and confluence areas to Unity Biotechnology Inc.Market Risk Summary & Proven Capital Preservation Methods - Newser
Is Unity Biotechnology Inc. stock reversal real or fakePortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Visualizing Unity Biotechnology Inc. stock with heatmapsJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
Is this a good reentry point in Unity Biotechnology Inc.Weekly Trade Analysis & Low Risk High Reward Trade Ideas - Newser
Intraday pattern recognizer results for Unity Biotechnology Inc.Portfolio Performance Report & Verified Chart Pattern Signals - Newser
Will Unity Biotechnology Inc. benefit from macro trendsIndex Update & Technical Pattern Based Buy Signals - Newser
Will Unity Biotechnology Inc. price bounce be sustainablePortfolio Risk Report & Risk Adjusted Buy/Sell Alerts - Newser
How to track smart money flows in Unity Biotechnology Inc.2025 AllTime Highs & Accurate Entry/Exit Alerts - Newser
Historical volatility pattern of Unity Biotechnology Inc. visualizedJuly 2025 Reactions & Low Risk Entry Point Guides - Newser
Volume spikes in Unity Biotechnology Inc. stock – what they mean2025 Market WrapUp & Daily Profit Maximizing Trade Tips - Newser
Multi factor analysis applied to Unity Biotechnology Inc.Market Growth Report & Entry Point Confirmation Alerts - Newser
Will Unity Biotechnology Inc. rebound enough to break even2025 Big Picture & Real-Time Stock Entry Alerts - Newser
Will a bounce in Unity Biotechnology Inc. offer an exitSell Signal & Free Safe Entry Trade Signal Reports - Newser
Tools to assess Unity Biotechnology Inc.’s risk profileMarket Performance Summary & AI Enhanced Trade Execution Alerts - Newser
Earnings visualization tools for Unity Biotechnology Inc.July 2025 Rallies & Safe Swing Trade Setup Alerts - Newser
Can a trend reversal in Unity Biotechnology Inc. lead to recoveryMarket Growth Summary & Weekly Breakout Watchlists - Newser
Does Unity Biotechnology Inc. show high probability of reboundWeekly Profit Analysis & Low Risk Profit Maximizing Plans - Newser
Has Unity Biotechnology Inc. formed a bullish divergence2025 Fundamental Recap & Weekly High Momentum Picks - Newser
How to forecast Unity Biotechnology Inc. trends using time series2025 Price Momentum & Advanced Technical Signal Analysis - Newser
Is it too late to sell Unity Biotechnology Inc.Market Movers & Daily Volume Surge Trade Alerts - Newser
Unity Biotechnology Inc. stock volume spike explainedMarket Volume Summary & Fast Moving Trade Plans - Newser
What candlestick patterns are forming on Unity Biotechnology Inc.July 2025 Trends & Stepwise Trade Signal Guides - Newser
Multi Factor Analysis Ranks Unity Biotechnology Inc. as Strong Buy2025 Fundamental Recap & Reliable Entry Point Alerts - beatles.ru
Unity Biotechnology Inc Stock (UBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):